1. Home
  2. BCRX vs PRVA Comparison

BCRX vs PRVA Comparison

Compare BCRX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.37

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$21.63

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
PRVA
Founded
1986
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BCRX
PRVA
Price
$8.37
$21.63
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$20.82
$31.17
AVG Volume (30 Days)
4.4M
803.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
381.40
63.64
EPS
N/A
0.02
Revenue
$25,186,000.00
$2,122,842,000.00
Revenue This Year
N/A
$18.19
Revenue Next Year
$12.55
$10.72
P/E Ratio
N/A
$1,081.50
Revenue Growth
N/A
22.26
52 Week Low
$6.00
$18.78
52 Week High
$11.22
$26.51

Technical Indicators

Market Signals
Indicator
BCRX
PRVA
Relative Strength Index (RSI) 42.68 43.14
Support Level $8.13 $21.20
Resistance Level $8.68 $24.09
Average True Range (ATR) 0.33 0.60
MACD -0.04 -0.13
Stochastic Oscillator 25.21 35.83

Price Performance

Historical Comparison
BCRX
PRVA

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

Share on Social Networks: